Desmoid Tumor
29
4
7
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
28%
5 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (29)
A Study in Adults With Desmoid Tumors
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Individual Patient Compassionate Use of Nirogacestat
Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
A Study of AL102 in Patients With Progressing Desmoid Tumors
Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Burden of Disease and Living Situation in Desmoid Patients
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Quality of Life of Patients With Desmoid-type Fibromatosis
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor